Log in
Enquire now

Clinical studies on immunotherapy

Clinical studies on immunotherapy
Clinical studies on microbiome
Clinical studies on vitiligo
Clinical studies on radiography
List of companies in Mohandas Pai's investment portfolio
List of SBIR/STTR awards granted to Metrica, Inc.
Clinical Studies where
Health Conditions in Trial
is
ImmunotherapyImmunotherapy
Name
Description
NCT Number
Health Conditions in Trial
Clinical Trial Start Date
Study Completion Date
Clinical Trial Study Type
‌
The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients

NCT04397575
Chemotherapy
Chemotherapy
Surgery
Surgery
Cancer
Cancer
Immunotherapy
Immunotherapy
Social inequality
Social inequality
‌
Radiotherapy
April 3, 2020
September 30, 2021
Observational
‌
Sintilimab Combined With Fruquintinib/Regorafenib ± Radiotherapy for Third-line Treatment of Advanced Metastatic Colorectal Cancer

NCT06356584
Colorectal cancer
Colorectal cancer
Immunotherapy
Immunotherapy
‌
Targeted therapy
‌
Radiotherapy
April 1, 2024
October 1, 2026
Interventional
‌
FOLFOX Chemotherapy Plus Fruquintinib and Sintilimab After First-line Treatment in Unresectable Hepatocellular Carcinoma

NCT06446154
Immunotherapy
Immunotherapy
Hepatocellular carcinoma
Hepatocellular carcinoma
July 1, 2024
July 1, 2026
Interventional
‌
Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

NCT06307249
Chemotherapy
Chemotherapy
Colorectal cancer
Colorectal cancer
Immunotherapy
Immunotherapy
Ovarian cancer
Ovarian cancer
‌
Targeted therapy
‌
Breast Cancer
‌
Lung Cancer
‌
Cancer
February 15, 2023
2027
Interventional
‌
Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma

NCT06413342
Immunotherapy
Immunotherapy
Esophageal cancer
Esophageal cancer
‌
Chemoradiotherapy
June 1, 2024
June 1, 2028
Interventional
‌
Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions

NCT06649838
Cervical cancer
Cervical cancer
Immunotherapy
Immunotherapy
‌
Biomarker
December 20, 2024
October 2, 2026
Observational
‌
Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)

NCT06012318
Immunotherapy
Immunotherapy
Esophageal cancer
Esophageal cancer
September 10, 2023
December 31, 2024
Observational
‌
De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma

NCT06313450
Immunotherapy
Immunotherapy
March 4, 2024
February 1, 2028
Interventional
‌
Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy

NCT04641884
Immunotherapy
Immunotherapy
‌
Bullous pemphigoid
April 1, 2020
April 1, 2021
Observational
‌
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC

NCT06241807
Immunotherapy
Immunotherapy
‌
Neoadjuvant therapy
June 6, 2023
December 31, 2026
Interventional
‌
Low-Dose Involved-Field Radiotherapy Plus Mmunochemotherapy for ESCC

NCT06603402
Immunotherapy
Immunotherapy
August 24, 2023
September 1, 2025
Interventional
‌
A Prospective Cohort Study of Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy

NCT06276088
Immunotherapy
Immunotherapy
‌
Biomarker
February 18, 2024
October 31, 2026
Observational
‌
Rehabilitation Needs for Hematologic Cancer Candidate for Hematopoietic Stem Cell Transplantation or CAR T-Cell Therapy

NCT06506396
Immunotherapy
Immunotherapy
‌
CAR T-Cell therapy
2024
2025
Observational
‌
The Role of Tumor-associated Macrophages in Colorectal Liver Metastases

NCT03888638
Colorectal cancer
Colorectal cancer
Immunotherapy
Immunotherapy
January 1, 2015
March 1, 2019
Observational
‌
Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment

NCT05813418
Immunotherapy
Immunotherapy
July 2, 2021
2024
Interventional
‌
Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia

NCT04057703
Immunotherapy
Immunotherapy
Immune thrombocytopenic purpura
Immune thrombocytopenic purpura
‌
Autoimmune hemolytic anemia
January 18, 2016
December 4, 2016
Observational
‌
Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients

NCT06429839
Chemotherapy
Chemotherapy
Immunotherapy
Immunotherapy
Esophageal cancer
Esophageal cancer
‌
Nimotuzumab
‌
Chemoradiotherapy
March 1, 2023
December 31, 2026
Interventional
‌
Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

NCT00720031
Immunotherapy
Immunotherapy
2000
2008
Interventional
‌
Association of Psychological Distress in Patients With Lung Cancer

NCT06218901
Immunotherapy
Immunotherapy
January 1, 2016
December 31, 2028
Observational
‌
Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma

NCT06542796
Immunotherapy
Immunotherapy
Hepatocellular carcinoma
Hepatocellular carcinoma
September 1, 2024
May 1, 2027
Interventional
‌
Application of PLDR External Irradiation Combined With Immune Checkpoint Inhibitors in Recurrent Cervical Cancer

NCT06232083
Immunotherapy
Immunotherapy
‌
Radiotherapy
February 1, 2024
February 1, 2026
Interventional
‌
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC

NCT06676449
Immunotherapy
Immunotherapy
‌
Radiotherapy
November 1, 2024
October 30, 2030
Interventional
‌
Changes in the Microenvironment of HPV-induced Head and Neck Cancers in West Indies and Metropolitan Population

NCT03580070
Immunotherapy
Immunotherapy
December 7, 2018
December 31, 2019
Observational
‌
68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer

NCT06608160
Immunotherapy
Immunotherapy
June 20, 2024
December 31, 2025
Observational
‌
Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer

NCT05025514
Cancer
Cancer
Immunotherapy
Immunotherapy
October 19, 2021
June 1, 2024
Observational
Results per page:
60 results
0 selected
60 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us